Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
CVS Group plc ( (GB:CVSG) ) has shared an update.
CVS Group plc reported a 6.6% increase in Group sales to £341.8m for the six months ended December 31, 2024, despite challenging market conditions in the UK. The company’s adjusted EBITDA grew by 4.5%, and their Healthy Pet Club membership rose by 1.4%. CVS is shifting its investment focus towards Australia due to regulatory stability, as evidenced by recent acquisitions there. Meanwhile, the UK operations face rising employment costs due to government budget changes. Despite these challenges, the company remains optimistic about future growth, supported by an improving employee engagement score and a strengthened management team.
More about CVS Group plc
CVS Group plc is an AIM-listed provider of veterinary services operating in the UK and Australia. The company is focused on delivering high-quality clinical services, supported by approximately 9,000 personnel, including 2,400 veterinary surgeons and 3,300 nurses. CVS operates around 460 veterinary practices, specialist referral hospitals, and out-of-hours sites, alongside laboratories, crematoria, and an online retail business named Animed Direct.
YTD Price Performance: 22.62%
Average Trading Volume: 312,259
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £723.1M
Learn more about CVSG stock on TipRanks’ Stock Analysis page.
